A U.S. judge ruled that Apple had infringed on one of Masimo Corp’s pulse oximeter patents by importing and selling certain Apple Watches with light-based pulse oximetry functionality and components, Masimo said on Tuesday.
Reuters
The United States International Trade Commission (USITC) will now consider whether to implement an import ban on these Apple Watches, the medical device maker said.
This is probably just the beginning of more maneuvering by both parties: Apple to work around the patent and avoid an import ban, and Masimo to gain leverage and get a license agreement which could be worth as high as $300 million according to Tamsin Bason, Bloomberg’s intelligence analyst.
